Psyence Biomedical: AdvisorShares reports 6.78% stake

PSYENCE BIOMEDICAL LTD.

Rhea-AI Filing Summary

PSYENCE BIOMEDICAL LTD. (PBM) is the issuer whose common shares AdvisorShares Trust reported beneficially owning. As of September 30, 2026, the reporting person held 258,538 shares, or 6.78% of the class. It reported sole voting and dispositive power over 258,538 shares and no shared voting or dispositive power.

Key Figures

Beneficial ownership: 258,538 shares Percent of class: 6.78% Sole voting power: 258,538 shares +3 more

6 metrics

Beneficial ownership 258,538 shares As of September 30, 2026

Percent of class 6.78% As of September 30, 2026

Sole voting power 258,538 shares AdvisorShares Trust

Sole dispositive power 258,538 shares AdvisorShares Trust

Shared voting power 0 shares AdvisorShares Trust

Shared dispositive power 0 shares AdvisorShares Trust

Key Terms

beneficially owned, Sole power to vote, Sole power to dispose

3 terms

beneficially owned financial

"Amount beneficially owned: 258,538"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Sole power to vote financial

"Sole power to vote or to direct the vote"

Sole power to dispose financial

"Sole power to dispose or to direct the disposition of"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many PBM shares does AdvisorShares Trust report owning?

AdvisorShares Trust reported beneficial ownership of 258,538 PBM common shares, representing 6.78% of the class as of September 30, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/05/2026 - 09:41 AM Accepted by SEC EDGAR 10/05/2026 - 09:40 AM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

PSYENCE BIOMEDICAL LTD.

(Name of Issuer)

Common shares, without par value

(Title of Class of Securities)

74449F407

(CUSIP Number)

09/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 74449F407

1

Names of Reporting Persons

AdvisorShares Trust

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 258,538.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 258,538.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

258,538.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.78 %

12

Type of Reporting Person (See Instructions)

IV

SCHEDULE 13G

Item 1.
(a)	Name of issuer: PSYENCE BIOMEDICAL LTD.
(b)	Address of issuer's principal executive offices: 121 Richmond Street West, Penthouse Suite 1300, Toronto, Ontario M5H 2K1
Item 2.
(a)	Name of person filing: AdvisorShares Trust
(b)	Address or principal business office or, if none, residence: 4800 Montgomery Lane, Suite 150 Bethesda, Maryland 20814
(c)	Citizenship: Delaware
(d)	Title of class of securities: Common shares, without par value
(e)	CUSIP Number(s): 74449F407
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 258,538
(b)	Percent of class: 6.78%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 258,538
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 258,538
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

AdvisorShares Trust

Signature:	/s/ Stefanie Little
Name/Title:	Stefanie Little - Chief Compliance Officer
Date:	10/02/2026